Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stille AB: Year-End Report 2021

Stille AB (publ) publishes the report for the fourth quarter and the full year of 2021. ”Strong sales despite current market situation”, summarizes Stille CEO Hanna Ernestam Wilkman.Revenues for the fourth quarter reached 59.6 MSEK (45.0), including recently acquired S&T whose sales exceeded expectations. Excluding the acquisition sales amounted to 44.0 MSEK despite challenges in the US for both business units.  ”To strengthen growth in the US-market, we have in December launched a new general surgery table, GS2®, in an exclusive collaboration with GE Healthcare, and signed an exclusive

Oncopeptides publishes year-end report 2021

STOCKHOLM — February 17, 2022 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has today published the year-end report 2021.Financial overview October-December · Net sales amounted to SEK -21.7 M (0.0) · Operating profit was SEK -389.8 M (- 511.6) · Net profit amounted to SEK -394.0 M (-513.0) · Profit per share, before and after dilution, amounted to SEK -5.23 (-7.59) · Cash balances at the end of the period amounted to SEK 362.2 M (840.3)  Financial overview

YIT’s Annual Review for 2021 published

YIT Corporation Stock Exchange Release 17 February 2022 at 9.00 a.m.YIT’s Annual Review for 2021 published YIT’s Annual Review for 2021 has been published today on the company’s website. The Annual Review consists of the highlights of 2021, report of the Board of Directors, consolidated financial statements, parent company’s financial statements, corporate governance statement and remuneration report. The report of the Board of Directors contains YIT’s statement of non-financial information. YIT publishes the Annual Review in accordance with European Single Electronic Format (ESEF)

Optomed Plc: Financial Statements Bulletin, January – December 2021

Optomed Plc         Stock Exchange Release    17 February 2022 at 9:00, Helsinki Optomed Plc: Financial Statements Bulletin, January – December 2021 October – December 2021 · Revenue decreased by 12.1 percent to EUR 3,552 (4,041) thousand · Devices segment revenue decreased by 23.6 percent to EUR 1,329 (1,738) thousand, as no camera deliveries were made to China during the quarter · Devices segment revenue continue strong growth in North America, Europe, and to the OEM channel · The Software segment revenue decreased by 3.5 percent to EUR 2,223 (2,303), as revenue from

Attana receives a Cell™ 250 instrument order from a European Life Science company

Attana has received an order for a Cell™ 250 instrument from a European Life Science company. This is the client’s second Attana instrument and is the result of a successful use and the client’s growth plans.The Cell™ 250 instrument will be installed during Q1 2022 and will positively affect Attana earnings in Q1 2022 and cash flow for the remainder of the year. “We strive to be close partner with our clients. This order is a result of this and our ability to grow together with our clients. We see good potential in increased further collaboration” comments Teodor Aastrup, CEO Attana.

Interim report Q4: A strong quarter ends a successful year

October – December 2021 · Net sales increased with 69 % and amounted to SEK 587 (348) million. · Organic growth amounted to 16 (25) %. · Adjusted EBIT increased to SEK 45 (8) million with a margin of 7.7 (2.4) %. · Profit for the period amounted to SEK 9 (1) million. · Earnings per share for the period before and after dilution amounted to SEK 0.16 (0.10). · The company’s B shares were listed during the quarter on Nasdaq Stockholm. In connection with the listing, a new share issue of SEK 528 million before transaction costs was made as well as an early redemption of the

Year-end report for Q4 and FY 2021

Profitable growth and very strong cash flow Quarter October-December 2021 · Net sales increased 5.9% to MSEK 641.4 (605.6) · The gross margin was 42.6% (40.3). · EBITA improved to MSEK 108.8 (77.4) · EBITA excl. items affecting comparability improved by MSEK 25.3 to MSEK 98.8 (73.5) · Net profit amounted to MSEK 75.6 (40.8) · Earnings per share amounted to SEK 4.68 (3.04) Full-year 2021 · Net sales rose 5.1% to MSEK 1,866.1 (1,774.9) · The gross margin was 38.4% (37.7) · EBITA improved to MSEK 124.1 (84.3) · EBITA excl. items affecting comparability

Year-end report for Duni AB (publ) January 1 – December 31, 2021

Growth with margins under pressureOctober 1 - December 31 · Net sales amounted to SEK 1,552 m (1,181), corresponding to a 31.4% increase in sales. Adjusted for exchange rate movements, net sales increased by 33.6%. · Strong growth towards a weak fourth quarter of 2020. · Earnings per share after dilution amounted to SEK 0.18 (0.73). · New restrictions and pressure on margins from sharp increases in raw material and logistics costs affected the quarter. January 1 – December 31 · Net sales amounted to SEK 5,061 m (4,501), corresponding to a 12.4% increase in sales.

Kojamo plc: Kojamo’s Board of Directors resolved on the long-term incentive plan’s performance period 2022–2024

Kojamo plc Stock Exchange Release, 17 February 2022 at 8:45 a.m. EETKojamo’s Board of Directors resolved on the long-term incentive plan’s performance period 2022–2024 Kojamo plc maintains a long-term incentive plan launched in 2021 for the group’s key employees with performance periods of 2021–2023, 2022–2024 and 2023–2025. The Board of Directors has resolved on the performance criteria, targets and target group for the performance period of 2022–2024. During the performance period of 2022–2024, the incentive plan is targeted at the members of the Management Team and other key

Year end report 2021 Scandinavian Biogas. New long-term target for 2030, 3 TWh biogas production, mainly Bio-LNG

Significant events in the fourth quarter of 2021 · Sales volumes for the period are the highest of the year. · Stable positive cash flow from operating activities. · In Sweden, the investment project Stockholm bio-LNG (liquid biogas) has been launched. · In Norway, the Skogn II project is on track, and the plant has received ISCC certification. · Klimatklivet has granted investment aid of SEK 154 million for the project in Mönsterås. RESULTS fourth QUARTER 2021 · Energy sold increased by 7.4% to 93.3 (86.9) GWh. · Net sales totalled SEK 104.8 (82.3) million,

CapMan Real Estate sells attractive high-street retail and office property in central Oslo

CapMan Real Estate press release 17 February 2022 at 8:30 am EET CapMan Real Estate sells attractive high-street retail and office property in central Oslo CapMan Nordic Real Estate II Fund has sold the 4,700 sqm property Lille Grensen 5 located in central Oslo to Arctic Securities for NOK 488 million. The property was originally acquired by CapMan Real Estate in December 2017. Since acquisition, the fund has signed several leases with new well-known tenants, carried out substantial refurbishment works and transformed the property to a core asset with long stable income. “

Apetit Group’s profitability lower than in the previous year – Positive overall development in Food Solutions

Apetit Plc, Financial Statements Review on 17 February 2022 at 08:30 a.m.Apetit Plc: Financial Statements Release 1 January to 31 December 2021 Apetit Group’s profitability lower than in the previous year – Positive overall development in Food Solutions October–December 2021, continuing operations* · Net sales amounted to EUR 83.0 (82.0) million · EBITDA was EUR 2.2 (2.7) million · Operating profit was EUR 0.5 (1.1) million January–December 2021, continuing operations* · Net sales amounted to EUR 283.9 (292.9) million · EBITDA was EUR 9.2 (10.1) million ·

Ahlstrom-Munksjö Aspa Bruk and Axolot Solutions evaluate a new technology for phosphorus purification

Ahlstrom-Munksjö Aspa Bruk and Axolot Solutions will in a joint project during a three months-period perform an extensive test activity aiming at reducing the phosphorus emissions from Aspa Bruk.The project is based on Axolot’s electrochemical AxoPur[®] 2.0 process and the trial is planned to continue until the start of the summer. The AxoPur system to be installed for the trial will have a capacity of 30 m[3] /h and it will treat a part of the relevant process water flow. Provided that the trial is successful, the system may be expanded to take care of the entire relevant flow of process

Bravida provides security solutions at Tidaholm Prison for an order value of approximately SEK 145 to 200 million

Bravida is to provide new installation, expansion and supplementing of teletechnical security systems at the Swedish Prison and Probation Service’s Tidaholm Prison. The contract has an order value of approximately SEK 145 to 200 million.Tidaholm Prison is classed as a security level 1 prison and is to expand its existing 180 places to about 320 places. The project is a collaborative project and will be implemented together by the Swedish Prison and Probation Service and Bravida. The assignment also includes the installation of alarm and access control systems, CCTV systems, intercom

Strong order intake and launch of a new product segment

The fourth quarter: October – The full year 2021: January – DecemberDecember · Net sales amounted to 1,120 MSEK (1,200). · Net sales increased 20 · Order intake increased 67 percent to 1,558percent to 324 MSEK (269). MSEK (933). · Order intake increased 111 · Operating profit increased to 118 MSEKpercent to 484 MSEK (230). (115). · Order backlog increased 43 · Adjusted operating profit amounted to 120percent to 1,557 MSEK (1,087). MSEK (135). · Operating profit increased · Net profit after tax increased to

Quarterly Report October to December 2021

SAAS BUSINESS GROWING AND FINANCING SECUREDOCTOBER TO DECEMBER 2021 · Net sales amounted to 9.8 MSEK (9.7) · Net sales adjusted*1 amounted to 10.4 MSEK (10.2) · Recurring revenues adjusted amounted to 9.4 MSEK (8.1) · Rolling 12 months recurring revenues adjusted amounted to 36.7 MSEK (33.9) · Usage revenues adjusted amounted to 4.0 MSEK (3.5) · Gross margin increased to 72% (65) · EBITDA adjusted amounted to -16.6 MSEK (-15.5) · Earnings per share amounted to -0.3 SEK (-1.0) JANUARY TO DECEMBER 2021 · Net sales amounted to 38.9 MSEK (53.8) · Net sales

Scandion Oncology announces its results for the fourth quarter and year-end 2021

Scandion Oncology (Scandion) today announces its fourth quarter and year-end report for 2021. The following is taken from the report. Bo Rode Hansen, President and CEO, comments “The fourth quarter completed a busy and successful 2021 for Scandion in which we transformed the company on substantially all accounts, increasing its fundamental value. We have prepared for the future with continued focus on fundamental value creation and are poised to enter the right partnerships for Scandion when the data are ready.” Key Figures & Highlights TDKK Q4 2021 Q4

Scandinavian Biogas defines long term target for 2030 – 3 TWh biogas production, mainly Bio-LNG

Scandinavian Biogas Fuels International AB (SBF) defines its long-term growth target. The European biogas market is experiencing a paradigm shift and developing very fast especially in the Bio-LNG (liquid biogas) market. Clear evidence has been already seen for fast demand growth in the heavy transportation market segment. Maritime and industrial usage expected to follow as well.The market for heavy transportation vehicles is expected to grow from 2.800 to 280.000 vehicles in 2020s (source: NGVA), customer segment demanding substantial share of energy to be Bio-LNG. For the same period the

Year-end Report 2021 - Another record quarter

Financial - 1 Oct 2021 – 31 Dec 2021 · Net sales amounted to MSEK 89.6 (MSEK 10.4), an increase of 764%. · Adjusted EBITDA amounted to MSEK 12 (MSEK 4.9), an increase of 148%, adjusted for currency effects and non- recurring costs. * · EBITDA amounted to MSEK 11.6 (MSEK 4.9). · EBIT amounted to MSEK 10,6 (MSEK 4.4), an increase of 143%. · Cash flow from operating activities before changes in working capital amounted to MSEK 11.6 (MSEK 2.2) during the quarter. · Earnings for shares during the quarter amounted to SEK 0.3. Normalized for a split of shares during previous

Thunderful Group Year-End Report January–December 2021

Strongest quarter for Thunderful Group so far. Growth and improved profitability in distribution, lower profitability but organic growth in Games.FOURTH QUARTER OCTOBER–DECEMBER 2021 · Revenue increased 7.6% to 1,386.7 MSEK (1,288.3). · Adjusted EBITA rose 22.0% to 117.6 MSEK (96.4), corresponding to an adjusted EBITA margin of 8.5% (7.5). · Adjusted EBITDA increased 37.9% to 140.9 MSEK (102.2), corresponding to an adjusted EBITDA margin of 10.2% (7.9). · Operating profit (EBIT) increased 23.5% to 83.7 MSEK (67.8), corresponding to an operating margin of 6.0% (5.3). ·

Year-end report 2021

Record sales and continued high utilisation in transport operationsFourth quarter · Consolidated net sales increased by 37.9 percent to SEK 131.8 million (95.6). · Operating profit (EBIT) increased to SEK 24.7 million (14.3). · Earnings per share after dilution amounted to SEK 0.75 (0.47). Full-year 2021, January-December 2021 · Consolidated net sales increased by 9.1 percent to SEK 438.0 million (401.3). · Operating profit (EBIT) decreased to SEK 56.2 million (60.4). · Earnings per share after dilution amounted to SEK 1.68 (1.82).  · The Board of Directors

RugVista Group AB (publ) year-end report 2021

Outstanding full-year financial performance Fourth quarter 2021 highlights · Net revenue was SEK 218.8 (210.5) million representing a growth of 4.0% (55.3%). · Organic net revenue growth was 7.0%. · Gross margin increased to 64.9% (61.2%). · EBIT was SEK 40.3 (39.1) million and EBIT margin was 18.4% (18.6%). · Profit for the period was SEK 31.2 (30.4) million. · Earnings per share and per diluted share was SEK 1.50 (1.50) and 1.50 (1.46), respectively. · The average NPS (Net Promotor Score) value was 67 (66). January – December 2021 highlights · Net revenue

Kojamo plc’s Financial Statements and Board of Directors’ Report 2021 have been published

Kojamo plc Stock Exchange Release, 17 February 2022 at 8:30 a.m. EETKojamo plc’s Financial Statements and Board of Directors’ Report 2021 have been published Kojamo plc’s Financial Statements and Board of Directors’ Report 2021 have been published today. The Financial Statements includes the consolidated financial statements, the parent company financial statements and the Auditor’s Report. In addition, the company has today published separate Corporate Governance Statement and Remuneration Report for the year 2021. The Financial Statements in Finnish are, for the second time, and The

There are no items matching the current filter
There are no more items matching the current filter
Back to top